{
  "id": 15885872,
  "title": "Abbott Laboratories Reaffirms FY26 Adj. EPS Outlook - Update",
  "url": "https://urgent.news/2026/10/21/abbott-laboratories-reaffirms-fy26-adj-eps-outlook-update",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-21T11:45:14.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/abbott-laboratories-reaffirms-fy26-adj-eps-outlook-update"
  },
  "original_language": "en",
  "account": null,
  "summary": "(RTTNews) - While reporting financial results for the third quarter on Wednesday, healthcare company Abbott Laboratories (ABT) provided adjusted earnings guidance for the fourth quarter and reaffirmed its adjusted earnings outlook for the full-year 2026.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}